A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level

@article{He2012ARO,
  title={A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level},
  author={Andy He and E. Hersh},
  journal={Current Medical Research and Opinion},
  year={2012},
  volume={28},
  pages={1873 - 1880}
}
  • Andy He, E. Hersh
  • Published 2012
  • Medicine
  • Current Medical Research and Opinion
  • Abstract Background: An intranasal (IN) formulation of ketorolac was recently FDA approved in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. Scope: The aim of this paper is to provide an overview of the clinical pharmacology, pharmacokinetics, efficacy, and tolerability of IN ketorolac. Databases used for this literature search include PubMed, International Pharmaceutical Abstracts, Cochrane Library and… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to compare the efficacy and safety of ketorolac sublingual with fentanyl intranasal used in our hospital for pain control in children undergoing bilateral… Expand
    ConditionsOtitis Media, Pain, Postoperative
    InterventionDrug
    Ketorolac Tromethamine – Routes and Clinical Implications
    • 27
    Recent advances in the pharmacological management of acute and chronic pain.
    • 49
    • Highly Influenced
    • PDF
    Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels.
    • 19
    • Highly Influenced
    Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
    • C. Li, Chunyan Li, +4 authors W. Lu
    • Chemistry, Medicine
    • 2014
    • 33

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 27 REFERENCES
    Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study.
    • 24
    • Highly Influential
    • PDF
    Intranasal ketorolac for acute postoperative pain
    • 33
    • Highly Influential